Is the Short Physical Performance Battery a Useful Outcome Measure in Chronic Obstructive Pulmonary Disease

This study is currently recruiting participants.
Verified January 2012 by Royal Brompton & Harefield NHS Foundation Trust
Sponsor:
Collaborator:
Medical Research Council
Information provided by (Responsible Party):
Royal Brompton & Harefield NHS Foundation Trust
ClinicalTrials.gov Identifier:
NCT01515709
First received: January 10, 2012
Last updated: January 18, 2012
Last verified: January 2012

January 10, 2012
January 18, 2012
April 2011
December 2012   (final data collection date for primary outcome measure)
Mortality rate [ Time Frame: 36 months ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT01515709 on ClinicalTrials.gov Archive Site
  • Hospitalisation rate [ Time Frame: 36 months ] [ Designated as safety issue: No ]
  • Healthcare resource usage [ Time Frame: 36 months ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
Is the Short Physical Performance Battery a Useful Outcome Measure in Chronic Obstructive Pulmonary Disease
Is the Short Physical Performance Battery a Useful Outcome Measure in Patients With Chronic Obstructive Pulmonary Disease ?

Patients with Chronic Obstructive Lung Disease (COPD) often develop muscle problems, particularly in their legs which makes them more limited in what they can do. The Short Physical Performance Battery (SPPB) is a simple test of standing balance, usual walking speed and ability to stand from a chair. The SPPB may be a useful measure to predict leg function.

This study aims to evaluate whether the SPPB is comparable with current exercise tests used in COPD patients, and whether it is useful in predicting disability, death and health resource usage over time.

Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

Any patient with a diagnosis of COPD.

  • Pulmonary Disease, Chronic Obstructive
  • Lung Diseases, Obstructive
  • Pulmonary Emphysema
  • Bronchitis, Chronic
  • Lung Diseases
  • Disease Progression
Not Provided
Chronic Obstructive Pulmonary Disease
Patients with a diagnosis of COPD

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
400
December 2015
December 2012   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Diagnosis of COPD

Exclusion Criteria:

  • Any patient in whom mobility and lower limb function have been significantly affected by a neuromuscular cause (eg. motor neurone disease), severe peripheral vascular disease or amputation
  • Any patient whom is deemed unsafe to exercise
  • Patients unable to complete the SPPB, walking tests and leg strength assessments.
Both
Not Provided
No
Contact: Samantha SC Kon, BSc MRCP 01895 823 737 ext 5021 lungresearch@rbht.nhs.uk
Contact: Jane L Canavan, PhD 01895 823 737 ext 5021 lungresearch@rbht.nhs.uk
United Kingdom
 
NCT01515709
2011LF001H
No
Royal Brompton & Harefield NHS Foundation Trust
Royal Brompton & Harefield NHS Foundation Trust
Medical Research Council
Principal Investigator: William DC Man, MRCP PhD NIHR Respiratory Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust
Royal Brompton & Harefield NHS Foundation Trust
January 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP